Nicholas Caezza, Deputy General Counsel of Butterfly Network, Inc., filed a Form 4 on September 4, 2026, disclosing the sale of 1,709 shares of Class A Common Stock on September 2, 2026, pursuant to the company's sell-to-cover policy for tax withholding obligations.
A Form 4 filed with the SEC on September 4, 2026, discloses that Christopher D. Brown, a director of 908 Devices Inc. (NASDAQ:MASS), sold 30,000 shares of common stock on September 2, 2026, under a pre-established Rule 10b5-1 trading plan.
Raymond Whittaker, a director of Consolidated Water Co. Ltd. (NASDAQ:CWCO), filed a Form 4 on September 4, 2026, disclosing the sale of 1,000 shares of common stock on September 3, 2026.
Kevin Michael O'Neill, CEO of PDx at GE HealthCare Technologies Inc. (NASDAQ:GEHC), filed a Form 4 on September 4, 2026, disclosing that 718 shares of common stock were withheld on September 3, 2026, to cover tax obligations tied to the vesting of restricted stock …
George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., filed a Form 4 on September 4, 2026, reporting the withholding of 112 shares of common stock on September 3, 2026, to satisfy tax obligations connected to the vesting of restricted stock units.
Minchung Kgil, Chief Financial Officer of Figure Technology Solutions, Inc., filed a statement of changes in beneficial ownership on September 4, 2026, reporting a transaction dated September 2, 2026, involving Class A Common Stock.
Philip Rackliffe, CEO of AIS at GE HealthCare Technologies Inc., filed a Form 4 on September 4, 2026, reporting the withholding of 798 shares of common stock on September 3, 2026, to satisfy tax obligations connected to the vesting of restricted stock units.
A Statement of Changes in Beneficial Ownership was filed on September 4, 2026, reporting that John Welch, a director of Greenlight Capital Re, Ltd. (NASDAQ:GLRE), received a restricted stock award of ordinary shares on September 3, 2026.
A Form 4 filed with the SEC on September 4, 2026, discloses that Nicole Dominique Rose Sapire Reich, a director of BBB Foods Inc (NYSE:TBBB), sold 7,623 Class A Common Shares on September 2, 2026.
Courtney Phillips, General Counsel and Corporate Secretary of Maze Therapeutics, Inc. (NASDAQ:MAZE), filed a Form 4 on September 4, 2026, disclosing four sales of common stock on September 2 and September 3, 2026, all conducted to satisfy tax withholding obligations tied to vesting restricted …